The long-term effect of prenatal progesterone treatment on child development, behaviour and health: a systematic

N E Simons1, M Leeuw1, J Van't Hooft1

  • 1Department of Obstetrics, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Insights

Prenatal progesterone treatment for preventing preterm birth showed no long-term effects on child development up to age 8. Further research is needed for outcomes after first-trimester exposure.

Area of Science:

  • Obstetrics and Gynecology
  • Developmental Pediatrics
  • Perinatal Medicine

Background:

  • Progesterone is commonly used in prenatal care to prevent preterm birth.
  • The long-term developmental effects of prenatal progesterone exposure on children are not well understood.

Purpose of the Study:

  • To systematically evaluate the long-term outcomes in children following prenatal progesterone treatment.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
  • Studies compared progesterone treatment during pregnancy to placebo or other interventions.
  • Data from five RCTs involving 4222 children aged 6 months to 8 years were analyzed.

Main Results:

  • Meta-analysis of two studies (n=890) found no significant difference in neurodevelopment (Bayley-III Cognitive Composite score at 2 years) between children exposed to prenatal progesterone and placebo.
  • No differences in other long-term outcomes were observed.
  • Heterogeneity limited further meta-analyses.

Conclusions:

  • Prenatal progesterone treatment for preterm birth prevention does not appear to confer benefit or harm on child development up to age 8.
  • There is a need for studies investigating the effects of early-pregnancy progesterone administration and longer-term developmental outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.7K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
589